bioRxivBiochemistry
How fragile we are. Influence of STimulator of INterferon Genes, STING, variants on pathogen recognition and immune response efficiency
J. Morere, C. Hognon, T. Miclot, T. Jiang, E. Dumont, G. Barone, E. Bignon, A. MONARI
Abstract
The STimulator of INterferon Genes (STING) protein is a cornerstone of the human immune response. Its activation by cGAMP upon the presence of cytosolic DNA stimulates the production of type I interferons and inflammatory cytokines which are crucial for protecting cells from infections. STING signaling pathway can also influence both tumor-suppressive and tumor-promoting mechanisms, rendering it an appealing target for drug design. In the human population, several STING variants exist and exhibit dramatic differences in their activity, impacting the efficiency of the host defense against infections. Understanding the differential molecular mechanisms exhibited by these variants is of utmost importance notably towards personalized medicine treatments against diseases such as viral infections (COVID-19, Dengue...), cancers, or auto-inflammatory diseases. Owing to micro-seconds scale molecular modeling simulations and post-processing by contacts analysis and Machine Learning techniques, we reveal the dynamical behavior of four STING variants (wild type, G230A, R293Q, and G230A-R293Q) and we rationalize the variability of efficiency observed experimentally. Our results show that the decrease of STING activity is linked to a stiffening of key-structural features of the binding cavity, together with changes of the interaction patterns within the protein.
- organism: human
- assay: protein structure
- research focus: protein folding & dynamics
- approach: deep learning
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Comparative Molecular, Innate, and Adaptive Impacts of Chemically Diverse STING Agonists
Nobuyo Mizuno, Dylan T. Boehm, … Victor R. DeFilippis·VaccinePeer-reviewed·Jun 13, 2025
- STING polymer structure reveals mechanisms for activation, hyperactivation, and inhibition
S. L. Ergun, D. Fernandez, … L. Li·bioRxiv·Feb 15, 2019
- STING Nuclear Partners Contribute to Innate Immune Signalling Responses
C. R. Dixon, P. Malik, … E. C. Schirmer·bioRxiv·Dec 21, 2020
- Fluorinated cGAMP analogs, which act as STING agonists and are not cleavable by poxins: structural basis of their function
Martin Klíma, Milan Dejmek, … Evžen Bouřa·StructurePeer-reviewed·Feb 6, 2024
- Characterization of a Novel Transmembrane Activating STING Agonist using Genetically Humanized Mice
Nobuyo Mizuno, Jinu Abraham, … Victor R. DeFilippis·Cell ReportsPeer-reviewed·Jun 1, 2026
- Computational insights into the conformational transition of STING: mechanistic, energetic considerations, and the influence of crucial mutations